# ASP Isotopes Inc.: filings

ASPI · Nasdaq · CIK 1921865 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aspi.md) · [Financials](/companies/aspi/financials.md) · [Filings](/companies/aspi/filings.md) · [Insiders](/companies/aspi/insiders.md)

## Reports and events: 153 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 120, 4 86, 144 29, CORRESP 17, 3 15, UPLOAD 13, 10-Q 12, 424B5 11, SCHEDULE 13G/A 8, EFFECT 6, NT 10-Q 6, S-8 6, S-1/A 5, SCHEDULE 13G 5, 10-K 4, 10-K/A 4, CB/A 4, DEF 14A 3, DRS/A 3, S-1 3, S-3 3, 424B3 2, 5 2, 8-K/A 2, D 2, DRSLTR 2, NT 10-K 2, S-3ASR 2, S-3MEF 2, SC 13G 2, 424B4 1, 8-A12B 1, ARS 1, CB 1, CERT 1, DRS 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:15 ET | [8-K](/filings/0001193125-26-431084.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-431084 |
| 2026-10-15 | 08:22 ET | [8-K](/filings/0001193125-26-422325.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422325 |
| 2026-10-02 | 06:01 ET | [8-K](/filings/0001477932-26-005971.md) | 7.01 Regulation FD disclosure | 0001477932-26-005971 |
| 2026-09-08 | 09:20 ET | [8-K](/filings/0001193125-26-384527.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-384527 |
| 2026-08-20 | 17:17 ET | [8-K](/filings/0001477932-26-005196.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001477932-26-005196 |
| 2026-08-20 | 08:05 ET | [8-K](/filings/0001193125-26-358072.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-358072 |
| 2026-08-18 | 08:05 ET | [8-K](/filings/0001193125-26-354745.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-354745 |
| 2026-08-14 | 17:14 ET | [10-Q](/filings/0001193125-26-352603.md) | Quarterly report, period 2026-06-30 | 0001193125-26-352603 |
| 2026-08-06 | 08:12 ET | [8-K](/filings/0001193125-26-336859.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-336859 |
| 2026-08-05 | 08:05 ET | [8-K](/filings/0001193125-26-333911.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-333911 |
| 2026-08-04 | 08:06 ET | [8-K](/filings/0001193125-26-331596.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-331596 |
| 2026-07-30 | 08:10 ET | [8-K](/filings/0001193125-26-324987.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324987 |
| 2026-07-28 | 08:16 ET | [8-K](/filings/0001193125-26-318936.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318936 |
| 2026-07-21 | 08:05 ET | [8-K](/filings/0001193125-26-309573.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-309573 |
| 2026-07-16 | 16:15 ET | [8-K](/filings/0001193125-26-306136.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-306136 |
| 2026-07-16 | 21:58 ET | [8-K](/filings/0001477932-26-004337.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-004337 |
| 2026-06-25 | 17:24 ET | [8-K](/filings/0001477932-26-004020.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004020 |
| 2026-06-25 | 10:15 ET | [8-K](/filings/0001193125-26-282048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-282048 |
| 2026-06-23 | 08:00 ET | [8-K](/filings/0001477932-26-003952.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-003952 |
| 2026-05-26 | 08:01 ET | [8-K](/filings/0001193125-26-237916.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-237916 |
| 2026-05-20 | 17:15 ET | [8-K](/filings/0001193125-26-232841.md) | 7.01 Regulation FD disclosure | 0001193125-26-232841 |
| 2026-05-20 | 16:26 ET | [10-Q](/filings/0001193125-26-232658.md) | Quarterly report, period 2026-03-31 | 0001193125-26-232658 |
| 2026-05-11 | 07:34 ET | [8-K](/filings/0001193125-26-215717.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-215717 |
| 2026-05-06 | 07:32 ET | [8-K](/filings/0001193125-26-207578.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-207578 |
| 2026-04-30 | 16:15 ET | [10-K/A](/filings/0001193125-26-197329.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197329 |
| 2026-04-13 | 08:05 ET | [8-K](/filings/0001477932-26-002140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-002140 |
| 2026-04-10 | 16:15 ET | [10-K](/filings/0001193125-26-151294.md) | Annual report, period 2025-12-31 | 0001193125-26-151294 |
| 2026-04-10 | 09:03 ET | [8-K](/filings/0001477932-26-002103.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-002103 |
| 2026-03-24 | 17:15 ET | [8-K/A](/filings/0001477932-26-001559.md) | 9.01 Financial statements and exhibits | 0001477932-26-001559 |
| 2026-03-24 | 09:39 ET | [8-K](/filings/0001477932-26-001545.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-001545 |
| 2026-03-23 | 09:15 ET | [8-K](/filings/0001477932-26-001524.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-001524 |
| 2026-03-10 | 08:22 ET | [8-K](/filings/0001477932-26-001256.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-001256 |
| 2026-03-06 | 08:30 ET | [8-K](/filings/0001477932-26-001216.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-001216 |
| 2026-03-05 | 07:49 ET | [8-K](/filings/0001477932-26-001176.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-001176 |
| 2026-02-23 | 08:15 ET | [8-K](/filings/0001477932-26-000963.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-000963 |
| 2026-02-19 | 09:25 ET | [8-K](/filings/0001477932-26-000899.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-000899 |
| 2026-02-17 | 08:00 ET | [8-K](/filings/0001477932-26-000834.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-000834 |
| 2026-01-30 | 17:00 ET | [8-K](/filings/0001477932-26-000555.md) | 1.01 Entry into a material agreement | 0001477932-26-000555 |
| 2026-01-29 | 07:30 ET | [8-K](/filings/0001477932-26-000494.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-000494 |
| 2026-01-12 | 17:00 ET | [8-K](/filings/0001477932-26-000162.md) | 5.02 Departure or appointment of officers or directors | 0001477932-26-000162 |
| 2026-01-07 | 09:28 ET | [8-K](/filings/0001477932-26-000055.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000055 |
| 2025-12-19 | 07:06 ET | [8-K](/filings/0001477932-25-009061.md) | 5.07 Shareholder vote results | 0001477932-25-009061 |
| 2025-12-18 | 07:34 ET | [8-K](/filings/0001477932-25-009035.md) | 7.01 Regulation FD disclosure | 0001477932-25-009035 |
| 2025-12-17 | 09:30 ET | [8-K](/filings/0001477932-25-009004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-009004 |
| 2025-12-08 | 17:00 ET | [8-K](/filings/0001477932-25-008843.md) | 5.02 Departure or appointment of officers or directors | 0001477932-25-008843 |
| 2025-12-03 | 17:51 ET | [8-K](/filings/0001477932-25-008735.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-008735 |
| 2025-11-28 | 08:30 ET | [8-K](/filings/0001477932-25-008651.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-008651 |
| 2025-11-25 | 16:33 ET | [DEF 14A](/filings/0001477932-25-008604.md) | Proxy statement, period 2025-12-08 | 0001477932-25-008604 |
| 2025-11-21 | 08:23 ET | [8-K](/filings/0001477932-25-008541.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008541 |
| 2025-11-19 | 16:31 ET | [10-Q](/filings/0001193125-25-288168.md) | Quarterly report, period 2025-09-30 | 0001193125-25-288168 |

Page 1 of 4. [Older](/companies/aspi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:17 ET. No prices; not investment advice.